Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Adakveo®

crizanlizumab
Oncology
Oncology
Global Product Site US Product Site USA

Afinitor Disperz®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor®/Votubia®

everolimus
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Aimovig®

erenumab
Neuroscience
Neuroscience
USA Product Site USA

Arzerra®

ofatumumab
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Azarga®/Azorga®

brinzolamide, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Beovu®

brolucizumab
Ophthalmology
Ophthalmology
Global USA

Cibacen®

benazepril hydrochloride
Cardiovascular, Renal and Metabolism
Established Medicines

Ciprodex®

ciprofloxacin, dexamethasone
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Comtan®

entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Netherlands Canada Turkey Japan

Cosentyx®

secukinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Diovan®

valsartan
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey Japan

Duotrav™

travoprost, timolol
Ophthalmology
Ophthalmology
Germany Australia Austria Poland Netherlands Canada Japan

Durezol®

difluprednate
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Egaten®

triclabendazole
Hepatology
Established Medicines
USA

Entresto®

sacubitril, valsartan
Cardiovascular, Renal and Metabolism
Cardiovascular, Renal and Metabolism
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Eucreas®

vildagliptin, metformin
Cardiovascular, Renal and Metabolism
Respiratory
Global Product Site Finland United Kingdom Austria Poland Netherlands

Exelon®

rivastigmine
Neuroscience
Established Medicines
USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exforge®

valsartan, amlodipine besylate
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

Exjade®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Extavia®

interferon beta-1b
Neuroscience
Neuroscience
USA Product Site USA Finland Germany United Kingdom Poland Canada

Farydak®

panobinostat
Oncology
Oncology
Global Product Site USA Germany Austria Poland Netherlands

Femara®

letrozole
Oncology
Oncology
USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey Japan

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release
Neuroscience
Established Medicines
USA Product Site USA

Galvus®

vildagliptin
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site Finland Australia United Kingdom Austria Poland Netherlands Turkey

Gilenya®

fingolimod
Neuroscience
Neuroscience
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Gleevec®/Glivec®

imatinib mesylate
Oncology
Oncology
Global Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Ilaris®

canakinumab
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Germany United Kingdom Austria Poland Netherlands Canada Turkey Japan

Ilevro®/Nevanac®

nepafenac
Ophthalmology
Ophthalmology
Global Product Site USA Germany Canada Australia Austria Poland Netherlands

Izba®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Jadenu®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Jakavi®

ruxolitinib
Oncology
Oncology
Global Product Site Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Kesimpta®

ofatumumab
Neuroscience
Neuroscience
USA Product Site USA

Kisqali®

ribociclib
Oncology
Oncology
Global Product Site USA Product Site

Kymriah™

tisagenlecleucel-T
Oncology
Oncology
Global Product Site USA Product Site

Lamisil®

terbinafine (terbinafine hydrochloride)
Infectious disease
Established Medicines
USA Germany Australia United Kingdom Poland Canada Turkey

Lescol®

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol® XL

fluvastatin sodium
Cardiovascular, Renal and Metabolism
Established Medicines
Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lucentis®

ranibizumab
Ophthalmology
Ophthalmology
Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Lutathera®

lutetium Lu 177 dotatate
Advanced Accelerator Applications
USA USA Product Site

Luxturna®

voretigene neparvovec
Ophthalmology
Ophthalmology
USA Product Site USA

Mayzent®

siponimod
Neuroscience
Neuroscience
USA Product Site USA

Mekinist®

trametinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Myfortic®

mycophenolic acid (as mycophenolate sodium)
Immunology and Dermatology
Immunology and Dermatology
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Neoral®/Sandimmune®

cyclosporine, USP Modified
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

NETSPOT®

gallium Ga 68 dotatate injection
Advanced Accelerator Applications
USA

Onbrez® Breezhaler®

indacaterol
Respiratory
Respiratory
Finland Germany Australia United Kingdom Poland Netherlands Canada Turkey Japan

Pataday™

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Patanol®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Product Site USA Australia Poland Netherlands Canada Japan

Pazeo®

olopatadine
Ophthalmology
Ophthalmology
Global Product Site USA Canada

Piqray®

alpelisib
Oncology
Oncology
USA Product Site USA

Proleukin®

aldesleukin
Oncology
Oncology
USA Product Site Germany United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey

Promacta®/Revolade®

eltrombopag
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Ritalin LA®

methylphenidate HCl modified release
Neuroscience
Established Medicines
USA Australia

Ritalin®

methylphenidate HCl
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Netherlands Canada Turkey Japan

Rydapt®

midostaurin
Oncology
Oncology
Global Product Site USA Product Site

Sandostatin LAR®

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin® SC

octreotide acetate
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Seebri Breezhaler®

glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Simbrinza®

brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Simulect®

basiliximab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Stalevo®

carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

Systane®

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Balance

propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Global Product Site

Systane® Ultra

polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
Global Product Site

Tabrecta™

capmatinib
Oncology
Oncology
USA Product Site

Tafinlar®

dabrafenib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI® Podhaler™

tobramycin
Respiratory
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tobradex®

tobramycin, dexamethasone
Ophthalmology
Ophthalmology
USA Germany Austria Poland Netherlands Canada

Travatan Z®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan® BAK-Free

travoprost
Ophthalmology
Ophthalmology
Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Trileptal®

oxcarbazepine
Neuroscience
Established Medicines
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Tyverb®

lapatinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide
Respiratory
Respiratory
Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Votrient®

pazopanib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Xolair®

omalizumab
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Zometa®

zoledronic acid
Oncology
Oncology
USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Zortress®/Certican®

everolimus
Immunology and Dermatology
Immunology and Dermatology
Global Product Site USA Product Site USA Germany Australia United Kingdom Austria Poland Netherlands Turkey

Zykadia®

ceritinib
Oncology
Oncology
Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey